CSIMarket


Greenlight Biosciences Holdings Pbc  (GRNA)
Other Ticker:  
 


 

Greenlight Biosciences Holdings Pbc

GRNA's Financial Statements and Analysis



Greenlight Biosciences Holdings Pbc reported III. Quarter net loss per share of $-0.27 compare to earnings per share of $0.00 in the same quarter a year ago and improved compare to net loss per share of $-0.42 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ -0.27 $  2 Mill
$-0.27     $+1M     +68.65 %



Greenlight Biosciences Holdings Pbc's Revenue rose by 68.65 % in III. Quarter (Sep 30 2022) year on year, to $2 million and declined by -2.04 % sequentially.


Greenlight Biosciences Holdings Pbc is Expected to report next financial results on March 30, 2023.

More on GRNA's Income Statement



Greenlight Biosciences Holdings Pbc's in III. Quarter recorded net loss of $-38.158 million, an increase from net loss of $-1.527 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-51.926 million realized in previous quarter.

More on GRNA's Growth

GRNA's Cash flow In III. Quarter company's net cash flow was $54 million, capital expenditures fell by